Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

41.71
-0.8200-1.93%
Post-market: 41.880.1700+0.41%19:59 EDT
Volume:11.67M
Turnover:489.94M
Market Cap:186.24B
PE:10.42
High:42.72
Open:42.47
Low:41.47
Close:42.53
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.39
T/O Rate:0.37%
Dividend:1.72
Dividend Rate:4.13%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.72
PE(LYR):11.52

Loading ...

Stock Markets Can't Rely on Tech to Power Gains Anymore

Dow Jones
·
Aug 03

Novo Nordisk A/S Expected to Post Earnings of Dkk4.99 a Share - Earnings Preview

Reuters
·
Aug 03

Earning Preview: Novo-Nordisk Q2 revenue expected to decrease by 6.01%, institutional views are neutral

Earnings Agent
·
Aug 02

Novo Nordisk (NYSE:NVO) Ziltivekimab Trial Fails In Late Stage Cardiovascular Study

Simply Wall St.
·
Aug 02

Is Novo Nordisk Stock (NVO) a Good Buy After Today’s Plunge?

TIPRANKS
·
Aug 01

Exchange Traded Funds Top 10 Percentage Losers

Dow Jones
·
Aug 01

Nasdaq Composite Index Rises 1% as Amazon Surges 15% After Results; Apple and Micron Fall as Memory Stocks Retreat

TradingKey
·
Aug 01

Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback

TIPRANKS
·
Aug 01

European Stocks Wipe Out Monthly Gains as Novo Nordisk and Universal Music Plunge

Deep News
·
Aug 01

Novo Nordisk A/S Stock (NVO) Moved Down by 8.75% on Jul 31: Key Drivers Unveiled

TradingKey
·
Aug 01

European Equities Mixed in Friday Trading; Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Trial

MT Newswires Live
·
Aug 01

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 01

Novo Nordisk Falls Over 10% in Largest Single-Day Drop in Nearly Five Months After Announcing Heart Drug Trial Failure

TradingKey
·
Jul 31

Novo Nordisk's Stock Slumps After Failed Trial - Adding to the Company's Woes

Dow Jones
·
Jul 31

Movement Alert|Novo-Nordisk A/S Falls 8.2% in Regular Trading, Heart Drug Ziltivekimab Fails Phase 3 ZEUS Trial Primary Endpoint

Market Focus
·
Jul 31

Novo Nordisk Heart Drug Trial Failure Triggers Pre-Market Plunge, Deepening Concerns Over Weight Loss Drug Reliance

Stock News
·
Jul 31

Sector Update: Healthcare

MT Newswires Live
·
Jul 31

Novo Nordisk Share Fall Seems Justified by Loss of Big Sales Opportunity

Dow Jones
·
Jul 31

Cardiac Drug Trial Failure Sinks Novo-Nordisk Stock Over 9%

Deep News
·
Jul 31

Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Phase 3 Trial; Shares Fall Pre-Bell

MT Newswires Live
·
Jul 31